2526 — Hangzhou Diagens Biotechnology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$20.80bn
- HK$20.75bn
- CNY164.42m
Annual cashflow statement for Hangzhou Diagens Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | — |
| Source: | PROSPECTUS | PROSPECTUS | |
| Standards: | IFRS | IFRS | — |
| Status: | Final | Final | fx Preliminary |
| Net Income/Starting Line | -56.2 | -43.4 | — |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 22.4 | 21.3 | — |
| Unusual Items | |||
| Equity in Net Earnings/Losses | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -21.2 | -21.3 | — |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -47.4 | -29.8 | — |
| Capital Expenditures | -24.2 | -24.2 | — |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -92.8 | 43.9 | — |
| Sale of Business | |||
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Change in Net Intangibles | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -117 | 19.7 | — |
| Financing Cash Flow Items | -3.97 | -0.47 | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 164 | 6.8 | — |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.468 | -3.31 | — |